Ajust text size (less) Ajust text size (more)
Adjust text size
 

Cancer medicines: The role of community pharmacists

Back to previous page
Online module
banner_image
Curated Content

Curated Content

 

Cancer Medicines: The role that community pharmacists play in supporting their customers

This course enables community pharmacists to understand the supply, safe handling, adverse effects, supportive therapies and potential issues surrounding oral anticancer treatments.
This education series of 6 modules provides practical learning activities and addresses issues encountered in the community pharmacy setting.

PSA proudly hosts this education on behalf of the Cancer Institute NSW as part of our commitment to meet pharmacists’ educational needs.

PSA-Credit-icons_group
CPD credits

Accreditation number: CX17124-9

This activity has been accredited for 6 hours of Group 1 CPD (or 6 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 6 hours of Group 2 CPD (or 12 CPD credits) upon successful completion of relevant assessment activities.

  • Module 1 - General principles in cancer treatment
    Learning Objectives
    After completing this module, pharmacists should be able to:
    • Apply knowledge of cancer and cancer therapy when reviewing a prescription for an oral anticancer medicine
    • Discuss the expanding role of community pharmacists in managing oral anticancer medicines.
    Competency standards
    Competency Standards (2016) addressed: 1.1.1, 1.1.2, 1.1.3, 1.1.4, 1.4.1, 1.4.3, 1.5.1, 2.1.2.
    Competency Standards (2010) addressed: 1.2.1, 1.3.1, 1.5.2.
  • Module 2 - Oral anticancer medicines prescriptions and protocols
    Learning Objectives
    After completing this module, pharmacists should be able to:
    • Explain the complexities in interpreting oral anticancer medicine prescriptions and treatment protocols
    • Apply knowledge of oral anticancer medicines when reviewing a prescription and a treatment protocol
    • List common medication errors to reduce the risk of future medication error occurrence.
    Competency standards
    Competency Standards (2016) addressed: 1.1.1, 1.1.2, 1.1.3, 1.1.4, 1.1.5, 1.2.1, 1.2.2, 1.2.3, 1.3.1, 1.3.2, 1.4.1, 1.4.2, 1.4.3, 1.5.1, 1.6.1, 1.6.2, 1.6.3, 2.1.2, 2.1.3, 2.1.4, 3.1.1, 3.1.2, 3.1.3, 3.2.2, 3.2.3, 3.2.5, 3.3.1, 3.3.2, 3.3.3, 4.5.2, 4.7.7.
    Competency Standards (2010) addressed: 1.1.1, 1.2.1, 1.2.2, 1.3.1, 1.3.2, 1.4.1, 1.4.2, 1.5.2, 4.1.1, 4.1.2, 4.1.3, 4.2.1, 4.2.2, 4.2.3, 4.3.1, 4.3.2, 4.3.3, 6.1.1, 6.1.2, 6.1.3, 6.2.1, 6.2.2, 6.2.4, 6.2.5.
  • Module 3 - Handling oral anticancer medicines and related waste
    Learning Objectives
    After completing this module, pharmacists should be able to:
    • List potential hazards associated with the handling of cancer medicines and related waste, including dose administration aids (DAA), spill management and patient counselling
    • Implement and follow processes to recognise and minimise risk of exposure when handling oral anticancer medicines and related waste.
    Competency standards
    Competency Standards (2016) addressed: 1.1.1, 1.1.2, 1.1.3, 1.1.4, 1.1.5, 1.2.1, 1.2.2, 1.2.3, 1.3.1, 1.4.1, 1.4.2, 1.4.3, 1.5.1, 2.1.2, 2.1.3, 2.1.4, 3.2.2, 3.2.3, 3.4.6, 3.4.3,4.4.5, 4.5.2, 4.5.3.
    Competency Standards (2010) addressed: 1.1.1, 1.2.1, 1.2.2, 1.3.1, 1.3.2, 1.5.2, 3.3.2, 3.5.1, 4.2.3, 5.4.1, 5.4.3.
  • Module 4 - Adverse effects and supportive therapies
    Learning Objectives
    After completing this module, pharmacists should be able to:
    • Explain the common adverse effects and toxicities associated with oral anticancer medicines
    • Apply knowledge of supportive therapies in the prevention and management of adverse effects
    • List symptoms that require immediate referral to a hospital or back to the treating physician.
    Competency standards
    Competency Standards (2016) addressed: 1.1.1, 1.1.2, 1.1.3, 1.1.4, 1.1.5, 1.4.1, 1.4.2, 1.4.3, 1.5.1, 1.6.2, 1.6.3, 2.1.2, 2.1.3, 2.1.4, 3.1.1, 3.1.2, 3.1.3, 3.2.2, 3.2.3, 3.2.5, 3.3.1, 3.3.2.
    Competency Standards (2010) addressed: 1.2.1, 1.2.2, 1.3.1, 1.3.2, 1.4.2, 1.5.2, 4.2.1, 4.2.2, 4.2.3, 4.3.3, 6.1.1, 6.1.2, 6.1.3, 6.2.1, 6.2.2, 6.2.3, 6.2.4.
  • Module 5 - Drug interactions
    Learning Objectives
    After completing this module, pharmacists should be able to:
    • Explain the common drug interactions associated with oral anticancer medicines
    • Apply a stepwise method to evaluate drug interactions when dispensing oral anticancer medicines.
    Competency standards
    Competency Standards (2016) addressed: 1.1.1, 1.1.2, 1.1.3, 1.1.4, 1.1.5, 1.4.1, 1.4.2, 1.4.3, 1.5.1, 1.6.2, 1.6.3, 2.1.2, 2.1.3, 2.1.4, 3.1.1, 3.1.2, 3.1.3, 3.2.2, 3.2.3, 3.2.5, 3.3.1, 3.3.2.
    Competency Standards (2010) addressed: 1.2.1, 1.2.2, 1.3.1, 1.3.2, 1.4.2, 1.5.2, 4.2.1, 4.2.2, 4.2.3, 4.3.3, 6.1.1, 6.1.2, 6.1.3, 6.2.1, 6.2.2, 6.2.4, 3.2.2, 3.2.3, 3.2.2.
  • Module 6 - Patient education in cancer treatment
    Learning Objectives
    After completing this module, pharmacists should be able to:
    • Apply general principles of cancer medicines when educating patients and/or carers on how to take their medication, to ensure they receive optimal benefit and to minimise medication administration errors
    • Apply education principles when providing counselling to patient and/or carers receiving oral anticancer medicines, on managing side effects and treatment adherence
    • Step by step counselling points with practical advice incorporating principles of oral anticancer medicines.
    Competency standards
    Competency Standards (2016) addressed: 1.1.1, 1.1.2, 1.1.3, 1.1.4, 1.1.5, 1.4.1, 1.4.2, 1.4.3, 1.5.1, 1.6.2, 1.6.3, 1.2.1, 1.2.2, 1.2.3, 1.3.1, 2.1.2, 2.1.3, 2.1.4, 3.1.1, 3.1.2, 3.1.3, 3.2.2, 3.2.3, 3.2.5, 3.3.1, 3.3.2.
    Competency Standards (2010) addressed: 1.1.1, 1.2.1, 1.2.2, 1.3.1, 1.3.2, 1.4.2, 1.5.2, 3.2.2, 4.2.3, 4.3.3, 6.1.1, 6.1.2, 6.1.3, 6.2.1, 6.2.2, 6.2.3, 6.2.4.

In order to access this content, you must be logged in.

This activity is available for members and non-members.

If you have an account, click here to login.

If you do not have an account, please register here.


This item is listed in the following categories: • Public CPD


Back

our vision: Improving Australia's health through excellence in pharmacist care

' • '